Investment Summary

SK bioscience Invests In FinaBio

On October 8, 2024, SK bioscience invested in life science company FinaBio

Investment Highlights
  • This is SK bioscience’s 2nd transaction in the Life Science sector.
  • This is SK bioscience’s 1st transaction in the United States.
  • This is SK bioscience’s 1st transaction in Maryland.

Investment Summary
Date 2024-10-08
Target FinaBio
Sector Life Science
Investor(s) SK bioscience
Deal Type Stake Purchase

Target

FinaBio

Rockville, Maryland, United States
FinaBio specializes in the research and development of conjugate vaccines for pneumoniae, meningococcal, typhoid, and other diseases. FinaBio was founded in 2006 and is based in Rockville, Maryland.

Search 200,291 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

SK bioscience

Seongnam-si, South Korea
Category Company
Sector Life Science
DESCRIPTION

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure. SK bioscience is based in Seongnam-si, South Korea.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Stake Purchase) 1 of 1
State (Maryland) 1 of 1
Country (United States) 1 of 1
Year (2024) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-10-02 IDT Biologika

Dessau-Rosslau, Germany

IDT Biologika is a life science company. IDT Biologika offers research, development and manufacturing of biologics for the global protection of human and animal health. IDT Biologika was founded in 1921 and is based in Dessau-Rosslau, Germany.

Buy -
Mergr

Product

Company

Legal